Icosapent ethyl for reduction in cardiovascular disease risk in adults with hypertriglyceridaemia.
- Published in:
- Australian Prescriber, 2024, v. 47, n. 6, p. 197, doi. 10.18773/austprescr.2024.050
- Publication type:
- Article
Works matching IS 03128008 AND DT 2024 AND VI 47 AND IP 6
Results: 9
1
2
Deucravacitinib for plaque psoriasis.
- Published in:
- Australian Prescriber, 2024, v. 47, n. 6, p. 195, doi. 10.18773/austprescr.2024.049
- Publication type:
- Article
3
Top 10 drugs 2023-24.
- Published in:
- Australian Prescriber, 2024, v. 47, n. 6, p. 194, doi. 10.18773/austprescr.2024.048
- Publication type:
- Article
4
Acute tacrolimus toxicity due to concomitant use of ritonavir (with nirmatrelvir as Paxlovid).
- Published in:
- Australian Prescriber, 2024, v. 47, n. 6, p. 192, doi. 10.18773/austprescr.2024.052
- By:
- Publication type:
- Article
5
Pharmacovigilance in Australia: how do adverse event reports from clinicians contribute to medicine and vaccine safety?
- Published in:
- Australian Prescriber, 2024, v. 47, n. 6, p. 186, doi. 10.18773/austprescr.2024.056
- By:
- Publication type:
- Article
6
Diagnosis and management of antiphospholipid syndrome.
- Published in:
- Australian Prescriber, 2024, v. 47, n. 6, p. 179, doi. 10.18773/austprescr.2024.055
- By:
- Publication type:
- Article
7
Oral health impacts of vaping.
- Published in:
- Australian Prescriber, 2024, v. 47, n. 6, p. 177, doi. 10.18773/austprescr.2024.051
- By:
- Publication type:
- Article
8
Therapeutic vapes for smoking cessation and nicotine dependence.
- Published in:
- Australian Prescriber, 2024, v. 47, n. 6, p. 171, doi. 10.18773/austprescr.2024.054
- By:
- Publication type:
- Article
9
Establishing a national standard to achieve better outcomes for people living with chronic obstructive pulmonary disease.
- Published in:
- Australian Prescriber, 2024, v. 47, n. 6, p. 168, doi. 10.18773/austprescr.2024.053
- By:
- Publication type:
- Article